Literature DB >> 11782103

T-helper-1 and T-helper-2 responses in psychiatric disorders.

M J Schwarz1, S Chiang, N Müller, M Ackenheil.   

Abstract

The expanding field of psychoneuroimmunology has markedly increased knowledge about the interference of the central nervous system and the immune system. Immunological abnormalities in psychiatric patients have been repeatedly described in the last century. Modern concepts of immunology and the growing knowledge of psychoneuroimmunology may help in understanding the distinct immunological mechanisms in psychiatric disorders. One of these concepts regarding the adaptive immune system is the discrimination between Th1-like cell-mediated and Th2-like antibody-related immune responses. This article systematically describes alterations of Th1- or Th2-specific parameters in the major psychiatric disorders schizophrenia, major depression, and Alzheimer's disease. There are several hints of associations of these two distinct arms of immune response with subgroups of schizophrenia and major depression. The immunological research in Alzheimer's disease has already led to a preclinical model of immunotherapy. Categorization of immune parameters may also help to identify a possible immune-related pathophysiology in psychotic and affective disorders, resulting in specific treatment strategies. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Year:  2001        PMID: 11782103     DOI: 10.1006/brbi.2001.0647

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  46 in total

Review 1.  The effects of shift work on physical and mental health.

Authors:  Matthias Vogel; Tanja Braungardt; Wolfgang Meyer; Wolfgang Schneider
Journal:  J Neural Transm (Vienna)       Date:  2012-04-10       Impact factor: 3.575

2.  Depression, mood, stress, and Th1/Th2 immune balance in primary breast cancer patients undergoing classical massage therapy.

Authors:  Michaela Krohn; Miriam Listing; Gracia Tjahjono; Anett Reisshauer; Eva Peters; Burghard F Klapp; Martina Rauchfuss
Journal:  Support Care Cancer       Date:  2010-07-20       Impact factor: 3.603

3.  Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants.

Authors:  Nefertiti C dupont; Kehui Wang; Pathik D Wadhwa; Jennifer F Culhane; Edward L Nelson
Journal:  J Reprod Immunol       Date:  2005-08       Impact factor: 4.054

4.  Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the "neuro-immune" system.

Authors:  János Kálmán; András Palotás; Anna Juhász; Agnes Rimanóczy; Marietta Hugyecz; Zsuzsa Kovács; Gabriella Galsi; Zoltán Szabó; Magdolna Pákáski; Liliána Z Fehér; Zoltán Janka; László G Puskás
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

Review 5.  Immune system to brain signaling: neuropsychopharmacological implications.

Authors:  Lucile Capuron; Andrew H Miller
Journal:  Pharmacol Ther       Date:  2011-02-17       Impact factor: 12.310

Review 6.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

7.  Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions.

Authors:  Madeline Li; Joanna K Soczynska; Sidney H Kennedy
Journal:  Curr Psychiatry Rep       Date:  2011-10       Impact factor: 5.285

Review 8.  [Immunology in schizophrenic disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

Review 9.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

10.  An investigation of symptoms predating CFS onset.

Authors:  Meredyth Evans; Morgan Barry; Young Im; Abigail Brown; Leonard A Jason
Journal:  J Prev Interv Community       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.